IGFBP3 increases the risk of BrS and is mediated by N-palmitoyl glycine A total of 69 circulating metabolites were nominally significant, and only one metabolite (N-palmitoyl glycine, PalGly) reached the Bonferroni-corrected threshold ( p < 0.05/1190) (Supplementary Data 9 ).
← all excerpts
N-palmitoyl glycine differentially modulates TRPM4 and TRPC5 and is causally linked to Brugada syndrome.
1
—
—